Shares of Moderna have tumbled 40% this year, Ark’s Genomic Revolution ETF nearly 50%.
Cathie Wood’s Ark Invest Buys Moderna Stock After $100 Billion Crash—And Sells Rival Vaccine Maker Pfizer
Shares of Moderna have tumbled 40% this year, Ark’s Genomic Revolution ETF nearly 50%.